Mapping the RNA therapeutics R&D landscape in 2022

Fueled by the successful utilisation of the mRNA Covid-19 vaccines, RNA therapeutics are expected to make larger strides in 2022

IN DEPTH

A cloudy day in paradise for pharma tax havens in Cayman Islands & Bermuda?

Comment

Briefing

Industry news

Pharma industry briefing

Covid-19 briefing

Comment

Restrictive Medicare coverage spells continued uncertainty for Aduhelm

2021: a record year for orphan therapies

Trikafta/Kaftrio continues to be a game-changer for cystic fibrosis patients

In Depth

Mapping the RNA therapeutics R&D landscape in 2022

A cloudy day in paradise for pharma tax havens in Cayman Islands & Bermuda?

Pharmaceutical Technology Excellence Awards 2021 – Winners Announced!

How technology could transform drug research in 2022

Anaesthesia drugs worst-hit by US drug shortages

In Data

Asia-Pacific sees the largest growth in metabolic disorders-related trials

The Middle East has seen the largest growth in infectious disease-related trials

Markets and indices

Macro-economic data

02/24/2024 13:22:51